Condition: Methamphetamine Use · Heart Failure · Sponsor: Oregon Health and Science University
The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.
This description comes directly from the study's public registry record.
Brian Chan, MD, MPH · 503-494-2010 · chanbri@ohsu.edu
Kellie Pertl, MPH · pertl@ohsu.edu
Always discuss trial participation with your own doctor first.
| Oregon Health & Science University | Portland, Oregon, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06461962